Insider Activity of Rachlin Evan Lockwood
According to the SEC Form 4 filings, Rachlin Evan Lockwood, being in a position of
- director at Iambic Therapeutics Inc.,оver the last 12 months, has bought 718750 shares for $11.5M, and sold 0 shares,over all time since 2026-10-16, has bought 718750 shares for $11.5M, and sold 0 shares.
Biography of Rachlin Evan Lockwood
No biography is available at this moment.